TOP2A and neoplasm: Clonogenic survival assays and in vivo tumor growth delay studies confirm that the observed increase in DNA damage translates to greater cell kill and longer tumor growth delay in combination treatments compared to Top2 poison alone, however dose-limiting toxicities were also observed.